GIA
BIO icon

GHP Investment Advisors’s Bio-Rad Laboratories Class A BIO Stock Holding History

GHP Investment Advisors’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.7K Hold
16
– – ﹤0.01% 909
2026
Q1 		$4.46K Hold
16
– – ﹤0.01% 917
2025
Q4 		$4.85K Hold
16
– – ﹤0.01% 825
2025
Q3 		$4.49K Hold
16
– – ﹤0.01% 802
2025
Q2 		$3.86K Buy
+16
New +$3.78K ﹤0.01% 822
2024
Q3 		– Sell
-17
Closed -$4.64K – 984
2024
Q2 		$4.64K Buy
+17
New +$4.94K ﹤0.01% 784

Other funds holding BIO

First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

GHP Investment Advisors's BIO Position: Q2 2026 in Review

GHP Investment Advisors held its Bio-Rad Laboratories Class A (BIO) position steady in Q2 2026 at 16 shares worth $4.7K. The position accounts for ﹤0.01% of the portfolio, ranked #909.

GHP Investment Advisors first reported a position in BIO in Q2 2024 and has held it in 6 quarters since. The position peaked at $4.85K in Q4 2025. 398 funds tracked by Wall St. Rank hold BIO as of Q2 2026.

  • GHP Investment Advisors held 16 shares of Bio-Rad Laboratories Class A worth $4.7K as of Q2 2026.
  • GHP Investment Advisors left its Bio-Rad Laboratories Class A share count unchanged in Q2 2026.
  • Bio-Rad Laboratories Class A made up ﹤0.01% of GHP Investment Advisors's portfolio in Q2 2026, its #909 holding.
  • GHP Investment Advisors first reported a position in Bio-Rad Laboratories Class A in Q2 2024 and has held it in 6 quarters since.
  • GHP Investment Advisors's Bio-Rad Laboratories Class A position peaked at $4.85K in Q4 2025.
  • 398 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2026.

Based on GHP Investment Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.